Related Experiment Videos
Pentoxifylline does not alter the response to inhaled grain dust
P J Jagielo1, J L Watt, T J Quinn
1Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242-1081, USA.
Chest
|May 1, 1997
Summary
Pentoxifylline (PTX) did not alter lung inflammation or airflow obstruction after corn dust extract (CDE) inhalation in healthy subjects. This study found no significant physiological or inflammatory differences between PTX and placebo groups.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Toxicology
Background:
- Grain dust inhalation can cause airway inflammation and airflow obstruction.
- Endotoxin in grain dust is a primary cause of these respiratory issues.
- Pentoxifylline (PTX) is known to reduce sepsis-induced lung inflammation.
Purpose of the Study:
- To investigate the effect of PTX on physiological and inflammatory responses to acute grain dust inhalation.
- To determine if PTX can mitigate airway inflammation and obstruction caused by corn dust extract (CDE).
Main Methods:
- A single-blinded, crossover study involving 10 healthy subjects.
- Subjects received PTX or placebo (PL) before and during CDE inhalation.
- Respiratory symptoms, lung function (FEV1, FVC), and inflammatory markers (leukocytes, neutrophils, TNF-alpha, IL-8) were measured.
Main Results:
- Both PTX and PL groups experienced respiratory symptoms and lung function decline after CDE exposure.
- No significant differences were observed in symptom frequency or lung function changes between PTX and PL groups.
- Inflammatory marker levels in blood and bronchoalveolar lavage (BAL) fluid did not differ significantly between the groups.
Conclusions:
- Pretreatment with PTX, at the doses used, did not alter the acute physiological or inflammatory effects of CDE inhalation.
- PTX does not appear to be effective in preventing acute lung inflammation and airflow obstruction from grain dust exposure in this study population.